Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Pavel, Hurník"'
Autor:
Iveta Putnová, Barbora Moldovan Putnová, Pavel Hurník, Jan Štembírek, Marcela Buchtová, Petra Kolísková
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Squamous cell carcinoma (SCC) of the head and neck originates from the mucosal lining of the upper aerodigestive tract, including the lip, tongue, nasopharynx, oropharynx, larynx and hypopharynx. In this review, we summarise what is currently known a
Externí odkaz:
https://doaj.org/article/34020c2b57254742812945fbef839f1a
Autor:
Tomáš Blažek, Marek Petráš, Pavel Hurník, Petr Matoušek, Lukáš Knybel, Zuzana Zděblová Čermáková, Jan Štembírek, Jakub Cvek, Renata Soumarová
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionIn the era of personalized medicine and treatment optimization, use of immune biomarkers holds promise for estimating the prognosis of patients with head and neck squamous cell carcinoma (HNSCC) undergoing definitive treatment.MethodsTo e
Externí odkaz:
https://doaj.org/article/f532011d5f7f4bf0866b6d48cc9402f5
Autor:
Pavel Hurník, Barbora Moldovan Putnová, Tereza Ševčíková, Eva Hrubá, Iveta Putnová, Josef Škarda, Martin Havel, Oldřich Res, Jakub Cvek, Marcela Buchtová, Jan Štembírek
Publikováno v:
BMC Oral Health, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Ameloblastic carcinoma and metastasising ameloblastoma are rare epithelial odontogenic tumours with aggressive features. Distinguishing between these two lesions is often clinically difficult but necessary to predict tumour behavi
Externí odkaz:
https://doaj.org/article/673c883fc97c4c0bbeba890c7662d8f9
Autor:
Pavel Hurník, Jana Režnarová, Zuzana Chyra, Oldřich Motyka, Barbora Moldovan Putnová, Zuzana Čermáková, Tomáš Blažek, Martin Fománek, Daria Gaykalova, Marcela Buchtová, Tereza Ševčíková, Jan Štembírek
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveOral squamous cell carcinoma (OSCC) originates from the mucosal lining of the oral cavity. Almost half of newly diagnosed cases are classified as advanced stage IV disease, which makes resection difficult. In this study, we investigated the
Externí odkaz:
https://doaj.org/article/fc7e3ac4bf56492794eeee61973864d4
Autor:
Valeria Skopelidou, Pavel Hurník, Vladimir Židlík, Lubomír Tulinský, Jiří Lenz, Tomáš Balner, Dušan Žiak, Patricie Delongová, Rudolf Karas, Miroslava Škripková, Matěj Jendřejek
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Sarcoidosis is a disease characterised primarily by lung tissue involvement. Extrapulmonary involvement, particularly in the genitourinary tract, is extremely rare, particularly when it comes to primary disease detection in this location. The gold st
Externí odkaz:
https://doaj.org/article/1059d8efe075496697f6df283d3960f8
Autor:
Valeria Skopelidou, Pavel Hurník, Lubomír Tulinský, Vladimir Židlík, Jiří Lenz, Patricie Delongová, Helena Hornychová, Patrik Flodr, Tomáš Jelínek, Ludmila Muroňová, Dušan Holub, Petr Džubák, Marián Hajdúch
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
Amyloidosis is a rare metabolic disorder primarily brought on by misfolding of an autologous protein, which causes its local or systemic deposition in an aberrant fibrillar form. It is quite rare for pulmonary tissue to be impacted by amyloidosis; of
Externí odkaz:
https://doaj.org/article/5d3b44f9f4df42ba8e3705192ece15a0
Autor:
Tomáš Blažek, Zuzana Zděblová Čermáková, Lukáš Knybel, Pavel Hurník, Jan Štembírek, Kamila Resová, Tereza Paračková, Martin Formánek, Jakub Cvek, Renata Soumarová
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Purpose We evaluated the efficiency and toxicity of stereotactic hypofractionated boost in combination with conventionally fractionated radiotherapy in the treatment of advanced floor of the mouth cancer. Methods Thirty-seven patients with a
Externí odkaz:
https://doaj.org/article/238e011452f1467c8d566c305e7f7ee4
Autor:
Pavel Hurník, Zuzana Chyra, Tereza Ševčíková, Jan Štembírek, Kateřina Smešný Trtková, Daria A. Gaykalova, Marcela Buchtová, Eva Hrubá
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Carcinomas of the oral cavity and oropharynx belong among the ten most common malignancies in the human population. The prognosis of head and neck squamous cell carcinoma (HNSCC) is determined by the degree of invasiveness of the primary tumor and by
Externí odkaz:
https://doaj.org/article/7c08e8d0d1a54f2892d0a45881e22b4e
Autor:
Zuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, Jan Štembírek, Tereza Paračková, Kamila Resová, Jakub Cvek, Tomáš Blažek, Lukáš Knybel, Martin Formánek, Mariam Gachechiladze, Markus Joerger, Alex Soltermann, Jozef Škarda, Oldřich Motyka, Jana Janoutová
Publikováno v:
Medicina, Vol 59, Iss 2, p 361 (2023)
Introduction: The incidence of advanced oral cavity and oropharyngeal cancers is generally high. Treatment outcomes for patients, especially those unfit for comprehensive cancer treatment, are unsatisfactory. Therefore, the search for factors to pred
Externí odkaz:
https://doaj.org/article/dc3fbdc18cc242049c3c14b69da5670d
Autor:
Jiří Lenz, Natálie Klubíčková, Nikola Ptáková, Veronika Hájková, Petr Grossmann, Petr Šteiner, Zdeněk Kinkor, Marián Švajdler, Michal Michal, Petra Konečná, Dominika Macháčová, Pavel Hurník, Michal Tichý, František Tichý, Michal Kyllar, Luděk Fiala, Miroslav Kavka, Michael Michal
Publikováno v:
Human Pathology. 134:19-29
Extraskeletal myxoid chondrosarcoma (EMC) is a rare sarcoma of uncertain lineage. Insulinoma-associated protein 1 (INSM1) has recently been described as a highly specific and sensitive immunohistochemical marker for EMC. The goal of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba8d3ccbf10f1ce41a95b7baf99166a
https://doi.org/10.1016/j.humpath.2022.12.005
https://doi.org/10.1016/j.humpath.2022.12.005